Clinical Trial Results:
A multicentre, double-blind, parallel, randomized, placebo-controlled study :
Evaluation of the efficacy and safety of Levocetirizine 5 mg and Desloratadine 5 mg
administered orally as capsules once daily, in the morning, over 2 weeks in patients
suffering from Seasonal Allergic Rhinitis (SAR) due to grass pollen
Summary
|
|
EudraCT number |
2004-002823-42 |
Trial protocol |
DE IT |
Global completion date |
12 Sep 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
23 Dec 2016
|
First version publication date |
23 Dec 2016
|
Other versions |
|
Summary report(s) |
synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.